Sandostatin® labeled with99mTc: In vitro stability, in vivo validity and comparison with111In-DTPA-octreotide

Peptide Research

Volumn 9, Issue 3, 1996, Pages 144-150

  Kolan, Hemender ^a   Li, Jinghua ^a   Thakur, Mathew L ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; OCTREOTIDE; PENTETIC ACID; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ANIMAL; ARTICLE; CARCINOMA; DRUG STABILITY; HUMAN; MALE; MOUSE; NUDE MOUSE; PROSTATE TUMOR; RAT; SCINTISCANNING; SPRAGUE DAWLEY RAT;

ANIMALS; CARCINOMA; DRUG STABILITY; HUMANS; INDIUM RADIOISOTOPES; MALE; MICE; MICE, NUDE; OCTREOTIDE; PENTETIC ACID; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TECHNETIUM;

EID: 0029658610     PISSN: 10405704     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Anderon, C.J., T.S. Pajeau, W.B. Edwards, E.L.C. Sherman, B.E. Rogers and M.J. Welch. 1995. In vitro and in vivo evaluation of copper-64-octreotide conjugates. J. Nucl. Med. 56:2315-2325.
2. Bajc, M., C. Ingvar and J. Palmer. 1996. Dynamic indium-111-pentreotide scintigraphy in breast cancer. J. Nucl. Med. 37:622-626.
3. Bakker, W.H., E.P. Krenning, W.A. Breeman, J.W. Köper, P.P. Kooij, J. Reubi, J.G. Klijn, T.J. Visser, R. Docter and S.W. Lamberts. 1990. Receptor scintigraphy with a radioiodinated somatostatin analog: radiolabeling, purification, biologic activity and in vivo application in animals. J. Nucl. Med. 31:1501 1509.
4. Bakker, W.H., R. Albert, C. Bruns, W.A. Breeman, L.J. Holland, P. Marbach, J. Pless, D. Pralet, B. Stolz and J.W. Köper. 1991. [' ' 'In-DTPA-D-PHEJ-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci. 49:1583-1591.
5. Bakker, W.H., E.P. Krenning, J. Reubi, W.A. Breeman, B. Setyono-Han, M. de Jong, P.P. Kooij, C. Bruns, P.M. van Haven and P. Marbach. 1991. In vivo application of [' ' 'In-DTPA-D-PHE]-octreotide for detection of somatostatin receptor-positive tumors in rats. Life Sci. 49:1593-1601.
6. ö.Breeman, W.A., D.J. Kwekkeboom, P.P. Kooij, W.H. Bakker, L.J. Hofland, T.J. Visser, G.J. Ensing, S.W. Lamberts and E.P. Krenning. 1995. Effect of dose and specific activity on tissue distribution of indium-111pentreotide in rats. J. Nucl. Med. 36:623-627.
7. T.Guhlke, S., H.J. Wester, C. Bruns and G. Stocklin. 1994. (2-[18F]Fluoroproprionyl(D)-phe')-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: synthesis, radiolabeling, in vitro validation and biodistribution in mice. Nucl. Med. Biol. 27:819-825.
8. Hoffland, L.J., M. van der Pluijm, P.M. van Koetsveld, M. de Jong, B. Setyono-Han, W.H. Bakker, O.K. Kwekkeboom, T.J. Visser and S.W. Lamberts. 1994. A new radiolabeled somatostatin analog [11 lln-DTPA-DPhel] RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [lllIn-DTPA-D-Phel] octreotide. Eur. J. Nucl. Med. 27:328-335.
9. Krenning, E.P., D.J. Kwekkeboom, W.H. Bakker, W.A. Breeman, P.P. Kooij, H.Y. Oei, M. van Hagen, P.T. Postema, M. de Jong and J.C. Reubi. 1993. Somatostatin receptor scintigraphy with [In-111-DTPA-D-Phe] and [I-123-Tyr-3] octreotide; the Rotterdam experience with more than 1000 patients. Eur.J.Nucl.Med. 20:716-731.
10. Lamberts, S.W., A. van der Lely, W. de Herder and L.J. Hofland. 1996. Octreotide. Lancet 334:246-254.
11. Moretti, J.M., M. Caglar, C. Boaziz, N. Caillat-Vigneron and J.F. Morere. 1995 Sequential functional imaging with Technetium99m hexakis-2-methoxyisobutylisonitrile and Indium-111-octreotide: Can we predict the response to chemotherapy in small cell lung cancer? Eur. J. Nucl. Med. 22:177-180.
12. Raynor, K. and T. Reisine. 1989. Analogs of somatostatin selectively label distinct subtypes of somatostatin receptors in rat brain. J. Pharmacol. Exp. Then 257:510-517.
13. Reubi, J.C., J. Laissue, B. Waser, U. Horisberger and J. Schaer. 1994. Expression of somatostatin receptors in normal, inflamed and neoplastic human gastrointestinal tissues. Ann. N.Y. Acad. Sci. 7.55:122-137.
14. Smith-Jones, P.M., B. Stolz, C. Bruns, A. Rainer, H.W. Reist, R. Fridrich and H.R. Macke. 1994. Gallium-67/gallium-68-[DFO]octreotide-a potential radiopharmaceutical for PET imaging of somatostatin receptorpositive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies. J. Nucl. Med. 35:317-325.
15. IS.Srkalovic, G., C. Ren-Zhi and A.V. Schaily. 1990. Evaluation of receptors for somatostatin in various tumors using different analogs. Ann. Clin. Endocrinol. Metabol. 70:661-669.
16. Tenenbaum, F., J. Lumbroso, M. Schlumberger, A. Mure, P.F. Plouin, B. Caillou and C. Parmentier. 1995. Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J. Nucl. Med. 36:1-6.
17. Tenenbaum, F., J. Lumbroso, M. Schlumberger, B. Caillou, P. Fragu and C. Parmentier. 1995. Radiolabeled somatostatin analog scintigraphy in differentiated thyroid carcinoma. J. Nucl. Med. 36:807-810.
18. IS.Thakur, M.L. and J. DeFulvio. 1991. Technetium-99m labeled monoclonal antibodies for immunoscintigraphy: simplified preparation and evaluation. J. Imrnunol. Methods 737:217-222.
19. Thakur, M.L., H.R. Kolan, S. Rifat, J. Li, A. Rux, E. John, G. Halmos and A.V. Schaily. Vapreotide labeled with Tc-99m for imaging tumors: preparation and preliminary evaluation. Int. J. Oncol. (In press).
20. 1H-NMR and computer modeling conformational analysis. J. Biol. Chem. 269:12583-12588.
21. Zamora, P.P., S. Gulkhe and H. Bender. 1995. Radiotherapy with Re-188-RC-160: a directly labeled somatostatin analog in athymic nude mice with PC-3 tumors (human prostate carcinoma). J. Nucl. Med. 3:42P.